Search

Your search keyword '"Bajeot, Anne-Sophie"' showing total 28 results
Start Over Author "Bajeot, Anne-Sophie"
28 results on '"Bajeot, Anne-Sophie"'

2. Patients non répondeurs au BCG

Author

Leon, Priscilla, Pradère, Benjamin, Neuzillet, Yann, Bajeot, Anne Sophie, Marcq, Gautier, Prost, Doriane, Thibault, Constance, Xylinas, Evanguelos, Allory, Yves, Audenet, François, Masson-Lecomte, Alexandra, Seisen, Thomas, Rouprêt, Morgan, and Roumiguié, Mathieu

Published
2024
Full Text
View/download PDF

4. Cost-analysis of robot-assisted radical cystectomy in Europe: A cross-country comparison

Author

Mjaess, Georges, Diamand, Romain, Aoun, Fouad, Assenmacher, Gregoire, Assenmacher, Christophe, Verhoest, Gregory, Holz, Serge, Naudin, Michel, Ploussard, Guillaume, Mari, Andrea, Tay, Andrea, Issa, Rami, Roumiguié, Mathieu, Bajeot, Anne Sophie, Umari, Paolo, Sridhar, Ashwin, Kelly, John, Hendricksen, Kees, Einerhand, Sarah, Mertens, Laura S., Sanchez-Salas, Rafael, Gallardo, Anna Colomer, Quackels, Thierry, Peltier, Alexandre, Pradere, Benjamin, Moschini, Marco, Roumeguère, Thierry, and Albisinni, Simone

Published
2023
Full Text
View/download PDF

5. Neoadjuvant chemotherapy does not increase peri-operative morbidity following radical cystectomy

Author

Arora, Amandeep, Zugail, Ahmed S., Pugliesi, Felipe, Cathelineau, Xavier, Macek, Petr, Barbé, Yann, Karnes, R. Jeffrey, Ahmed, Mohamed, Di Trapani, Ettore, Soria, Francesco, Alvarez-Maestro, Mario, Montorsi, Francesco, Briganti, Alberto, Necchi, Andrea, Pradere, Benjamin, D’Andrea, David, Krajewski, Wojciech, Roumiguié, Mathieu, Bajeot, Anne Sophie, Hurle, Rodolfo, Contieri, Roberto, Carando, Roberto, Teoh, Jeremy Yuen-Chun, Roupret, Morgan, Benamran, Daniel, Ploussard, Guillaume, Mir, M. Carmen, Sanchez-Salas, Rafael, and Moschini, Marco

Published
2022
Full Text
View/download PDF

6. Carboplatin-based adjuvant chemotherapy versus observation after radical cystectomy in patients with pN1-3 urothelial bladder cancer

Author

Afferi, Luca, Lonati, Chiara, Montorsi, Francesco, Briganti, Alberto, Necchi, Andrea, Mari, Andrea, Minervini, Andrea, Campi, Riccardo, di Trapani, Ettore, de Cobelli, Ottavio, Karnes, R. Jeffrey, Ahmed, Mohamed, Mir, M. Carmen, Algarra, Maria Asuncion, Rink, Michael, Zamboni, Stefania, Simeone, Claudio, Krajewski, Wojciech, Xylinas, Evanguelos, Soria, Francesco, Hendricksen, Kees, Einerhand, Sarah, Mattei, Agostino, Carando, Roberto, Roumiguié, Mathieu, Bajeot, Anne Sophie, Black, Peter C., Shariat, Shahrokh F., and Moschini, Marco

Published
2022
Full Text
View/download PDF

7. Immediate radical cystectomy versus BCG immunotherapy for T1 high-grade non-muscle-invasive squamous bladder cancer: an international multi-centre collaboration

Author

Lonati , Chiara, Afferi, Luca, Mari, Andrea, Minervini, Andrea, Krajewski, Wojciech, Borghesi, Marco, Schulz, Gerald B., Rink, Michael, Montorsi, Francesco, Briganti, Alberto, Colombo, Renzo, Martini, Alberto, Necchi, Andrea, Contieri, Roberto, Hurle, Rodolfo, Umari, Paolo, Zamboni, Stefania, Simeone, Claudio, Soria, Francesco, Marra, Giancarlo, Gontero, Paolo, Teoh, Jeremy Yuen-Chun, Klatte, Tobias, Bajeot, Anne-Sophie, Roumiguié, Mathieu, Rouprêt, Morgan, Masson-Lecomte, Alexandra, Laukhtina, Ekaterina, Valiquette, Anne Sophie, Mir, M. Carmen, Antonelli, Alessandro, Einerhand, Sarah M. H., Hendricksen, Kees, Carando, Roberto, Fankhauser, Christian D., Baumeister, Philipp, Mattei, Agostino, Shariat, Shahrokh F., and Moschini, Marco

Published
2022
Full Text
View/download PDF

10. Recommandations françaises du comité de cancérologie de l’AFU – Actualisation 2024–2026 : tumeurs de la voie excrétrice urinaire supérieure (TVES)

Author

Roumiguié, Mathieu, Seisen, Thomas, Masson-Lecomte, Alexandra, Prost, Doriane, Allory, Yves, Xylinas, Evanguelos, Leon, Priscilla, Bajeot, Anne Sophie, Pradère, Benjamin, Marcq, Gautier, Neuzillet, Yann, Thibault, Constance, Audenet, François, and Rouprêt, Morgan

Abstract

L’objectif de ce travail était de proposer une mise à jour des recommandations du Comité de cancérologie de l’Association française d’urologie pour la prise en charge des tumeurs de la voie excrétrice supérieure (TVES).

Published
2024
Full Text
View/download PDF

11. The prognostic value of high-grade prostate cancer pattern on MRI-targeted biopsies: predictors for downgrading and importance of concomitant systematic biopsies

Author

Manceau, Cécile, Fromont-Hankard, Gaëlle, Beauval, Jean-Baptiste, Lesourd, Marine, Almeras, Christophe, Bajeot, Anne-Sophie, Gautier, Jean-Romain, Soulié, Michel, Loison, Guillaume, Salin, Ambroise, Tollon, Christophe, Malavaud, Bernard, Roumiguié, Mathieu, and Ploussard, Guillaume

Published
2021
Full Text
View/download PDF

12. Comparing Robotic-Assisted to Open Radical Cystectomy in the Management of Non-Muscle-Invasive Bladder Cancer: A Propensity Score Matched-Pair Analysis

Author

Courboin, Etienne, primary, Mathieu, Romain, additional, Panetta, Valentina, additional, Mjaess, Georges, additional, Diamand, Romain, additional, Verhoest, Gregory, additional, Roumiguié, Mathieu, additional, Bajeot, Anne Sophie, additional, Soria, Francesco, additional, Lonati, Chiara, additional, Simeone, Claudio, additional, Simone, Giuseppe, additional, Anceschi, Umberto, additional, Umari, Paolo, additional, Sridhar, Ashwin, additional, Kelly, John, additional, Mertens, Laura S., additional, Sanchez-Salas, Rafael, additional, Colomer, Anna, additional, Cerruto, Maria Angela, additional, Antonelli, Alessandro, additional, Krajewski, Wojciech, additional, Quackels, Thierry, additional, Peltier, Alexandre, additional, Montorsi, Francesco, additional, Briganti, Alberto, additional, Teoh, Jeremy Y. C., additional, Pradere, Benjamin, additional, Moschini, Marco, additional, Roumeguère, Thierry, additional, and Albisinni, Simone, additional

Published
2023
Full Text
View/download PDF

13. Correction: Diamant et al. Effectiveness of Early Radical Cystectomy for High-Risk Non-Muscle Invasive Bladder Cancer. Cancers 2022, 14, 3797

Author

Diamant, Elliott, primary, Roumiguié, Mathieu, additional, Ingels, Alexandre, additional, Parra, Jérôme, additional, Vordos, Dimitri, additional, Bajeot, Anne-Sophie, additional, Chartier-Kastler, Emmanuel, additional, Soulié, Michel, additional, de la Taille, Alexandre, additional, Rouprêt, Morgan, additional, and Seisen, Thomas, additional

Published
2022
Full Text
View/download PDF

14. Selecting the Best Candidates for Cisplatin-based Adjuvant Chemotherapy After Radical Cystectomy Among Patients with pN+ Bladder Cancer

Author

Afferi, Luca, primary, Lonati, Chiara, additional, Montorsi, Francesco, additional, Briganti, Alberto, additional, Necchi, Andrea, additional, Mari, Andrea, additional, Minervini, Andrea, additional, Tellini, Riccardo, additional, Campi, Riccardo, additional, Schulz, Gerald Bastian, additional, Black, Peter C., additional, di Trapani, Ettore, additional, de Cobelli, Ottavio, additional, Karnes, R. Jeffrey, additional, Ahmed, Mohamed, additional, Mir, M. Carmen, additional, Algarra, Maria Asuncion, additional, Rink, Michael, additional, Zamboni, Stefania, additional, Mondini, Francesca, additional, Simeone, Claudio, additional, Antonelli, Alessandro, additional, Tafuri, Alessandro, additional, Krajewski, Wojciech, additional, Małkiewicz, Bartosz, additional, Xylinas, Evanguelos, additional, Soria, Francesco, additional, Sanchez Salas, Rafael, additional, Arora, Amandeep, additional, Cathelineau, Xavier, additional, Hendricksen, Kees, additional, Ammiwala, Maida, additional, Borghesi, Marco, additional, Chierigo, Francesco, additional, Teoh, Jeremy Yuen-Chun, additional, Mattei, Agostino, additional, Albisinni, Simone, additional, Roghmann, Florian, additional, Roumiguié, Mathieu, additional, Bajeot, Anne Sophie, additional, Maier, Elisabeth, additional, Aziz, Atiqullah, additional, Hurle, Rodolfo, additional, Contieri, Roberto, additional, Pradere, Benjamin, additional, Carando, Roberto, additional, Poyet, Cedric, additional, Alvarez-Maestro, Mario, additional, D'Andrea, David, additional, Shariat, Shahrokh F., additional, and Moschini, Marco, additional

Published
2022
Full Text
View/download PDF

15. Oncological Outcomes for Patients Harboring Positive Surgical Margins Following Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Retrospective Multicentric Study on Behalf of the YAU Urothelial Group

Author

Marcq, Gautier, primary, Afferi, Luca, additional, Neuzillet, Yann, additional, Nykopp, Timo, additional, Voskuilen, Charlotte S., additional, Furrer, Marc A., additional, Kassouf, Wassim, additional, Aziz, Atiqullah, additional, Bajeot, Anne Sophie, additional, Alvarez-Maestro, Mario, additional, Black, Peter, additional, Roupret, Morgan, additional, Noon, Aidan P., additional, Seiler, Roland, additional, Hendricksen, Kees, additional, Roumiguie, Mathieu, additional, Pang, Karl H., additional, Laine-Caroff, Paul, additional, Xylinas, Evanguelos, additional, Ploussard, Guillaume, additional, Moschini, Marco, additional, and Sargos, Paul, additional

Published
2022
Full Text
View/download PDF

17. Cost-analysis of robot-assisted radical cystectomy in Europe: A cross-country comparison

Author

Mjaess, Georges, primary, Diamand, Romain, additional, Aoun, Fouad, additional, Assenmacher, Gregoire, additional, Assenmacher, Christophe, additional, Verhoest, Gregory, additional, Holz, Serge, additional, Naudin, Michel, additional, Ploussard, Guillaume, additional, Mari, Andrea, additional, Tay, Andrea, additional, Issa, Rami, additional, Roumiguié, Mathieu, additional, Bajeot, Anne Sophie, additional, Umari, Paolo, additional, Sridhar, Ashwin, additional, Kelly, John, additional, Hendricksen, Kees, additional, Einerhand, Sarah, additional, Mertens, Laura S., additional, Sanchez-Salas, Rafael, additional, Gallardo, Anna Colomer, additional, Quackels, Thierry, additional, Peltier, Alexandre, additional, Pradere, Benjamin, additional, Moschini, Marco, additional, Roumeguère, Thierry, additional, and Albisinni, Simone, additional

Published
2022
Full Text
View/download PDF

18. Adjustable Continence Therapy (ACT®) balloons to treat female stress urinary incontinence: effectiveness, safety and risk factors of failure and complication

Author

de Guerry, Marie-Liesse, primary, Demeestere, Amélie, additional, Bergot, Christophe, additional, de Hauteclocque, Astrid, additional, Hascoet, Juliette, additional, Bajeot, Anne-Sophie, additional, Ternynck, Camille, additional, Gamé, Xavier, additional, Peyronnet, Benoît, additional, Capon, Grégoire, additional, Perrouin-Verbe, Marie-Aimée, additional, and Biardeau, Xavier, additional

Published
2022
Full Text
View/download PDF

19. Predictive Factors of Early Postoperative Complications After Robot-Assisted Radical Cystectomy for Urothelial Bladder Carcinoma

Author

Mermier, Marie, primary, Baron, Pierre, additional, Roumiguié, Mathieu, additional, Bajeot, Anne-Sophie, additional, Pignot, Geraldine, additional, Lannes, François, additional, Ploussard, Guillaume, additional, Gasmi, Anis, additional, Bensalah, Karim, additional, Perrot, Ophélie, additional, Rouprêt, Morgan, additional, Bruyère, Franck, additional, Pradere, Benjamin, additional, and Verhoest, Gregory, additional

Published
2022
Full Text
View/download PDF

20. Adjustable continence therapy (ACT®) balloons to treat neurogenic and non‐neurogenic female urinary incontinence

Author

Demeestere, Amélie, primary, Guerry, Marie‐Liesse, additional, Bergot, Christophe, additional, Hauteclocque, Astrid, additional, Hascoet, Juliette, additional, Gamé, Xavier, additional, Bajeot, Anne‐Sophie, additional, Peyronnet, Benoit, additional, Capon, Grégoire, additional, Perrouin‐Verbe, Marie‐Aimée, additional, and Biardeau, Xavier, additional

Published
2021
Full Text
View/download PDF

21. Continuing acetylsalicylic acid during Robotic-Assisted Radical Cystectomy with intracorporeal urinary diversion does not increase hemorrhagic complications: results from a large multicentric cohort

Author

Albisinni, Simone, primary, Diamand, Romain, additional, Mjaess, Georges, additional, Assenmacher, Gregoire, additional, Assenmacher, Christophe, additional, Loos, Shirley, additional, Verhoest, Gregory, additional, Holz, Serge, additional, Naudin, Michel, additional, Ploussard, Guillaume, additional, Mari, Andrea, additional, Di Maida, Fabrizio, additional, Minervini, Andrea, additional, Aoun, Fouad, additional, Tay, Andrea, additional, Issa, Rami, additional, Roumiguié, Mathieu, additional, Bajeot, Anne Sophie, additional, Simone, Giuseppe, additional, Anceschi, Umberto, additional, Umari, Paolo, additional, Sridhar, Ashwin, additional, Kelly, John, additional, Hendricksen, Kees, additional, Einerhand, Sarah, additional, Sanchez-Salas, Rafael, additional, Colomer, Anna, additional, Quackels, Thierry, additional, Peltier, Alexandre, additional, Montorsi, Francesco, additional, Briganti, Alberto, additional, Pradere, Benjamin, additional, Moschini, Marco, additional, and Roumeguère, Thierry, additional

Published
2021
Full Text
View/download PDF

22. MP52-19 ADJUSTABLE CONTINENCE THERAPY (ACT®) BALLOONS AND FEMALE URINARY INCONTINENCE: EFFICACY, SAFETY AND RISK FACTORS FOR FAILURE AND COMPLICATIONS

Author

de GUERRY, Marie-Liesse, primary, Demeestere, Amélie, additional, Bergot, Christophe, additional, de Hauteclocque, Astrid, additional, Hascoet, Juliette, additional, Gamé, Xavier, additional, Bajeot, Anne-Sophie, additional, Peyronnet, Benoît, additional, Capon, Grégoire, additional, Perrouin-Verbe, Marie-Aimée, additional, and Biardeau, Xavier, additional

Published
2021
Full Text
View/download PDF

23. French AFU Cancer Committee Guidelines – Update 2024–2026: Non-muscle invasive bladder cancer (NMIBC)

Author

Roumiguié, Mathieu, Leon, Priscilla, Xylinas, Evanguelos, Allory, Yves, Audenet, François, Bajeot, Anne Sophie, Marcq, Gautier, Prost, Doriane, Thibault, Constance, Masson-Lecomte, Alexandra, Seisen, Thomas, Pradère, Benjamin, Rouprêt, Morgan, and Neuzillet, Yann

Abstract

To update the CCAFU recommendations for the management of non-muscle invasive bladder cancer (NMIBC).

Published
2024
Full Text
View/download PDF

24. French AFU Cancer Committee Guidelines – Update 2024–2026: Muscle-invasive bladder cancer (MIBC)

Author

Roumiguié, Mathieu, Marcq, Gautier, Neuzillet, Yann, Bajeot, Anne Sophie, Allory, Yves, Sargos, Paul, Leon, Priscilla, Audenet, François, Xylinas, Evanguelos, Pradère, Benjamin, Prost, Doriane, Seisen, Thomas, Thibault, Constance, Masson-Lecomte, Alexandra, and Rouprêt, Morgan

Abstract

To update the CCAFU recommendations for the management of muscle-invasive bladder cancer (MIBC).

Published
2024
Full Text
View/download PDF

25. French AFU Cancer Committee Guidelines – Update 2024–2026: Upper urinary tract urothelial cancer (UTUC)

Author

Roumiguié, Mathieu, Seisen, Thomas, Masson-Lecomte, Alexandra, Prost, Doriane, Allory, Y., Xylinas, Evanguelos, Leon, Priscilla, Bajeot, Anne Sophie, Pradère, Benjamin, Marcq, Gautier, Neuzillet, Yann, Thibault, Constance, Audenet, François, and Rouprêt, Morgan

Abstract

The purpose of this study was to propose an update of the French guidelines from the national committee ccAFU on upper tract urothelial carcinomas (UTUC).

Published
2024
Full Text
View/download PDF

26. Defining the Morbidity of Robot-Assisted Radical Cystectomy with Intracorporeal Urinary Diversion: Adoption of the Comprehensive Complication Index.

Author

Albisinni, Simone, Diamand, Romain, Mjaess, Georges, Aoun, Fouad, Assenmacher, Gregoire, Assenmacher, Christophe, Verhoest, Gregory, Holz, Serge, Naudin, Michel, Ploussard, Guillaume, Mari, Andrea, Minervini, Andrea, Tay, Andrea, Issa, Rami, Roumiguié, Mathieu, Bajeot, Anne Sophie, Simone, Giuseppe, Anceschi, Umberto, Umari, Paolo, and Sridhar, Ashwin

Subjects
URINARY diversion, CYSTECTOMY, SURGICAL robots, SURGICAL complications, PATIENTS' attitudes, CLINICAL trials, BLADDER cancer
Abstract

Background and Objective: The Clavien–Dindo Classification (CDC) only reports the postoperative complication of highest grade. It is thus of limited value for radical cystectomy, after which patients usually experience multiple complications. The Comprehensive Complication Index (CCI) is a novel scoring system, which incorporates all postoperative events in one single value. The study aimed to adopt the CCI for the evaluation of complications in patients undergoing robot-assisted radical cystectomy (RARC) with intracorporeal urinary diversion (ICUD) and explore its advantages in the analysis of the morbidity of RARC with ICUD. Patients and Methods: A multicentric cohort of 959 patients undergoing RARC+ICUD between 2015 and 2020, whose complications are encoded in local prospective registries. Postoperative complications at 30 days were assessed using both the CDC and CCI. The CCI was calculated using an online tool (assessurgery.com). Risk factors for overall, major complications (CDC ≥III), and CCI were evaluated using uni- and multivariable logistic and linear regressions. To analyze the potential advantage of using the CCI in clinical trials, a sample size calculation of a hypothetic clinical trial was performed using as endpoint reduction of morbidity with either the CDC or CCI. Results: Overall, 885 postoperative complications were reported in 507 patients (53%). The CCI improved the definition of postoperative morbidity in 22.6% of patients. Male sex and neobladder were associated with major complications and to a significant increase in CCI on adjusted regressions. In a hypothetical clinical trial, 80 patients would be needed to demonstrate a ten-point reduction in CCI, compared with 186 needed to demonstrate an absolute risk reduction of 20% in overall morbidity using the CDC. Conclusion: CCI improves the evaluation of postoperative morbidity by considering the cumulative aspect of complications compared with the CDC. Implementing the CCI for radical cystectomy would help reducing sample sizes in clinical trials. Clinical Trial Registration number: NCT03049410. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

27. Adjustable continence therapy (ACT®) balloons to treat neurogenic and non‐neurogenic female urinary incontinence.

Author

Demeestere, Amélie, de Guerry, Marie‐Liesse, Bergot, Christophe, de Hauteclocque, Astrid, Hascoet, Juliette, Gamé, Xavier, Bajeot, Anne‐Sophie, Peyronnet, Benoit, Capon, Grégoire, Perrouin‐Verbe, Marie‐Aimée, and Biardeau, Xavier

Subjects
URINARY stress incontinence, ARTIFICIAL sphincters, URINARY incontinence, SURGICAL complications, NEUROLOGICAL disorders, SPHINCTERS, FEMALES
Abstract

Aims: To compare efficacy and safety between neurogenic and non‐neurogenic women after adjustable continence therapy (ACT®) balloons implantation to treat stress urinary incontinence (SUI) due to intrinsic sphincter deficiency. Methods: In the present retrospective multicentric study, all neurogenic and non‐neurogenic women implanted with ACT® balloons between 2000 and 2018 were considered for inclusion. Efficacy was compared 1 year after implantation, and women were allocated in three different groups as follows. Success: maximum 1 pad per day and patient's impression of improvement assessed using a numeral rating scale (NRS) ≥8/10. Improvement: decrease of daily pad use and/or NRS ≥5/10. Failure: increase or stability of daily pad use or NRS <5/10. Overall surgical complications and explantations were compared 1 year after implantation. Results: Among the 277 included women, 51 presented with a neurologic underlying disease. Mean age at implantation was 68.5 years. There was no significant difference in efficacy between neurogenic and non‐neurogenic women with a success rate of 39.2% and 36.3%, respectively (p = 0.69). Similarly, improvement rate was reported to be 31.4% and 33.6%, in neurogenic and non‐neurogenic women, respectively (p = 0.92). The overall surgical complications rate (24% vs. 34.5%, p = 0.15) and the explantation rate (19.6% vs. 28.8%, p = 0.18) were not significantly different. Conclusion: ACT balloons may be proposed to treat mixed or SUI in females with ISD. Efficacy and safety profiles appear to be similar in both neurogenic and non‐neurogenic patients. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

28. Continuing acetylsalicylic acid during Robotic-Assisted Radical Cystectomy with intracorporeal urinary diversion does not increase hemorrhagic complications: results from a large multicentric cohort.

Author

Albisinni, Simone, Diamand, Romain, Mjaess, Georges, Assenmacher, Gregoire, Assenmacher, Christophe, Loos, Shirley, Verhoest, Gregory, Holz, Serge, Naudin, Michel, Ploussard, Guillaume, Mari, Andrea, Di Maida, Fabrizio, Minervini, Andrea, Aoun, Fouad, Tay, Andrea, Issa, Rami, Roumiguié, Mathieu, Bajeot, Anne Sophie, Simone, Giuseppe, and Anceschi, Umberto

Subjects
*BLOOD loss estimation, *ASPIRIN, *URINARY diversion, *CYSTECTOMY, *SURGICAL complications, *PLATELET aggregation inhibitors, *BLOOD transfusion
Abstract

Objectives: To evaluate whether continuing the antiplatelet drug acetylsalicylic acid≤100mg (ASA) during Robotic-assisted radical cystectomy (RARC) with intracorporeal urinary diversion (ICUD) increases the risk of peri-and postoperative hemorrhagic complications and overall morbidity. Indeed, guidelines recommend interrupting antiplatelet therapy before radical cystectomy; however, RARC with ICUD is associated to reduced estimated blood loss and blood transfusions compared to its open counterpart.Methods: Data from a multicentric European database were analyzed. All participating centers maintained a prospective database of patients undergoing RARC with ICUD. We identified patients receiving antiplatelet therapy by acetylsalicylic acid ≤100mg. Patients were divided into three groups: those not taking acetylsalicylic acid (no-ASA), those where ASA was continued perioperatively (c-ASA) and those where ASA was interrupted perioperatively (i-ASA). Estimated blood loss and peri-and post-operative transfusions were recorded. Hemorrhagic complications, ischemic, thrombotic and cardiac morbidity was recorded and classified using the Clavien-Dindo score by a senior urologist.Results: 640 patients were analyzed. Patients on acetylsalicylic acid were significantly older and had more comorbidities. No significant difference was found for estimated blood loss between no-ASA, c-ASA and i-ASA (280 vs. 300 vs. 200ml respectively; P = 0.09). Similarly, no significant difference was found for intraoperative (5% vs. 9% vs. 11%; P = 0.07) and postoperative transfusion rate (11% vs. 13% vs. 18%; P = 0.17). Higher ischemic complications were noted in the i-ASA group compared to no-ASA and c-ASA (4% vs. 0.6% vs. 1.4%; P = 0.03). On uni and multivariate logistic regression, continuing acetylsalicylic acid was not significantly associated to either major complications or post-operative transfusions.Conclusions: Peri-operative acetylsalicylic acid continuation in RARC with ICUD does not increase hemorrhagic complications. Interrupting acetylsalicylic acid peri-operatively may expose patients to a higher risk of ischemic events. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results